Mark Worthington Athira Pharma, Inc. (ATHA) insider trading activity

ATHA Quotes by TradingView

Mark Worthington is GENERAL COUNSEL of Athira Pharma, Inc.. Currently has a direct ownership of 34,452 shares of ATHA, which is worth approximately $90,264. The most recent transaction as insider was on Jan 05, 2024, when has been sold 2,412 shares (Common Stock) at a price of $2.91 per share, resulting in proceeds of $7,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.5K
0% 3M change
28.25% 12M change
Total Value Held $90,264

Mark Worthington Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2024
SELL
Open market or private sale
$7,018 $2.91 p/Share
2,412 Reduced 6.54%
34,452 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 21.34%
36,864 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
$18,718 $2.41 p/Share
7,767 Added 22.43%
26,864 Common Stock
Jun 23 2022
SELL
Open market or private sale
$7,032 $2.69 p/Share
2,614 Reduced 12.04%
19,097 Common Stock
Jun 22 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 31.53%
21,711 Common Stock
May 18 2022
BUY
Grant, award, or other acquisition
$23,976 $7.06 p/Share
3,396 Added 22.48%
11,711 Common Stock
MW

Mark Worthington

GENERAL COUNSEL
Bothell, WA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATHA